Latest Industry Insights
Industry Insight
Gene Expression Analysis in Cancer Research
We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
Industry Insight
Building a Greener Future: Biobank Information Management Systems as Catalysts for Environmental Sustainability
Discover ways for decarbonization in biobanking and learn how a biobank information management system (BIMS) can reduce the carbon footprint of biobanks.
Industry Insight
Unlocking the “Morpholome” With AI-Powered Imaging
Technology Networks had the pleasure of speaking with Dr. Maddison Masaeli, co-founder and chief executive officer at Deepcell to learn about the REM-I platform, a single-cell analysis tool that utilizes AI-powered imaging to magnify insights into a cell’s phenotype and function.
Industry Insight
Flagship Facility Supports Advanced Analytical Science
We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Industry Insight
Curing the Image Analysis Headache with Deep Learning
Misha Bashkurov explores how image analysis software with deep learning capabilities can directly address the convoluted and confusing process of traditional image analysis, which often leads to user frustration, bias results, time lost and increased costs.
Industry Insight
Expanding the Short-Read Sequencing Space With Novel RNA-Sequencing Library Preparation Workflows
This article discusses the methodology of using common archived biospecimens for RNA sequencing in oncology applications, such as tumor profiling, introducing challenges and innovative solutions.
Industry Insight
Building the Future of Extracellular Vesicle Isolation
Hans van der Voorn tells us about some of the recent progress in the extracellular vesicle-based diagnostics and therapeutics landscape, particularly the need for industrial-scale EV isolation workflows.
Industry Insight
Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research
Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Industry Insight
Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies
Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
Industry Insight
Failing Faster To Succeed Sooner in Drug Discovery
Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
Advertisement